Moreover, cytoplasmic expression of KRAS was associated with resistance of pancreatic acinar cells to tumor-promoting KRAS mutations: KRAS mutants were expressed, but not properly located for exerting their function (Assi et al., 2020). The gene discussed is KRAS; the disease is neoplasm.